TriSalus Life Sciences Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, TriSalus Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of $8.80. The average 1-year stock price forecast is 111.54% higher than the current stock price, while the lowest is $7.00 (+68.27%) and the highest is $11 (+164.42%).

Price Target: $8.80 (+111.54%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$7.00	$8.80	$8.00	$11
Change	+68.27%	+111.54%	+92.31%	+164.42%

Analyst Ratings

The average analyst rating for TriSalus Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	6	6	5	4	4	4
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	6	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Frank Takkinen Lake Street	Lake Street	Buy Reiterates $8	Buy	Reiterates	$8	+92.31%	May 29, 2026
Jason McCarthy Maxim Group	Maxim Group	Buy Reiterates $10	Buy	Reiterates	$10	+140.38%	May 14, 2026
Justin Walsh JonesTrading	JonesTrading	Buy Reiterates $11	Buy	Reiterates	$11	+164.42%	May 13, 2026
William Plovanic Canaccord Genuity	Canaccord Genuity	Buy Maintains $7	Buy	Maintains	$7	+68.27%	May 13, 2026
Carl Byrnes Northland Securities	Northland Securities	Buy Reiterates $13 → $8	Buy	Reiterates	$13 → $8	+92.31%	Mar 23, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

52.40M

from 45.15M

16.05%

from 45.15M

Revenue Next Year

78.41M

from 52.40M

49.65%

from 52.40M

EPS This Year

-0.45

from -

EPS Next Year

-0.25

from -0.45

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	8.40M	12.40M	18.51M	29.43M	45.15M	52.40M
Revenue Growth	54.60%	47.58%	49.31%	58.99%	53.41%	16.05%
Gross Profit	7.21M	10.14M	15.91M	25.33M	38.19M	45.17M
Gross Margin	85.80%	81.79%	85.93%	86.06%	84.57%	86.20%
Operating Income	-24.03M	-36.44M	-50.18M	-36.17M	-26.95M	-22.51M
Net Income	-28.85M	-47.19M	-59.36M	-30.05M	-39.23M	-16.56M
EPS	-	-	-	-	-	-0.45
Free Cash Flow	-24.49M	-151.00K	-48.81M	-25.47M	-8.76M	832.00K
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	54.1M
Avg	52.4M
Low	48.6M

Revenue Growth

Revenue Growth	2026	2027	2028
High	19.8%
Avg	16.0%
Low	7.6%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.45
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-